The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Sanofi SA

NYSE: SNY
Last

(U.S.) $53.33

Today's change0.00 0.00%
Updated July 27 4:02 PM EDT. Delayed by at least 15 minutes.
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $53.33

Today's change0.00 0.00%
Updated July 27 4:02 PM EDT. Delayed by at least 15 minutes.

Sanofi SA closed at (U.S.)$53.33.

Over the last five days, shares are unchanged, but have gained 16.93% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $53.33
  • High--
  • Low--
  • Bid / Ask(U.S.) $53.26 / (U.S.) $53.32
  • YTD % change+16.93%
  • Volume0
  • Average volume (10-day)1,515,249
  • Average volume (1-month)1,554,523
  • Average volume (3-month)1,681,972
  • 52-week range(U.S.) $43.57 to (U.S.) $57.42
  • Beta1.10
  • Trailing P/E29.67×
  • P/E 1 year forward17.09×
  • Forward PEG2.11×
  • Indicated annual dividend(U.S.) $1.61
  • Dividend yield3.02%
  • Trailing EPS(U.S.) $1.80
Updated July 27 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.92%

Based on its net profit margin of 12.92%, Sanofi SA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.30%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue8,8909,1708,8688,146
Total other revenue--------
Total revenue8,8909,1708,8688,146
Gross profit6,1046,1296,0045,538
Total cost of revenue2,7863,0412,8642,608
Total operating expense7,4877,4857,0846,900
Selling / general / administrative2,4382,4652,3092,255
Research & development1,1991,3511,1461,188
Depreciation / amortization618620561624
Interest expense (income), net operating--------
Unusual expense (income)38018158155
Other operating expenses, total66-104670
Operating income1,4031,6851,7841,246
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,3061,5471,6451,152
Income after tax1,0861,3811,264802
Income tax, total220166381350
Net income1,0231,3391,190777
Total adjustments to net income--------
Net income before extra. items1,0231,3391,190777
Minority interest-32-27-31-27
Equity in affiliates-31-15-432
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,0231,3391,190777
Inc. avail. to common incl. extra. items1,0231,3391,190777
Diluted net income1,0231,3391,190777
Dilution adjustment--00--
Diluted weighted average shares1,3081,3461,3131,315
Diluted EPS excluding extraordinary itemsvalue per share0.780.990.910.59
Dividends per sharevalue per share0.001.580.000.00
Diluted normalized EPSvalue per share1.020.951.070.67